JGC
LONA

J. Goldman & Co’s LeonaBio Inc LONA Stock Holding History

J. Goldman & Co’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,750
Closed -$911K – 357
2022
Q1 		$911K Buy
+6,750
New +$712K 0.04% 259

Other funds holding LONA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

J. Goldman & Co's LONA Position: Q2 2022 in Review

J. Goldman & Co sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 4,745 shares — an estimated $641K sold.

J. Goldman & Co first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $1.41M in Q4 2021. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • J. Goldman & Co reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • J. Goldman & Co sold 4,745 LeonaBio Inc shares in Q2 2022, an estimated $641K.
  • J. Goldman & Co first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
  • J. Goldman & Co's LeonaBio Inc position peaked at $1.41M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.